XML 24 R15.htm IDEA: XBRL DOCUMENT
v3.23.1

Derivative Instruments | 3 Months Ended
--- | ---
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Instruments | Derivative Instruments The Company enters into derivative instrument agreements, including forward foreign currency exchange contracts, interest rate swaps, and cross currency swaps to manage risk in connection with changes in foreign currency and interest rates. The Company hedges committed exposures and does not engage in speculative transactions. The Company only enters into derivative instrument agreements with counterparties who have highly rated credit. As of March 31, 2023, the aggregate notional amount of the Company's outstanding interest rate contracts, cross currency swap contracts, EUR forward contract and CNY forward contracts were $577.5 million, $448.2 million, $321.7 million and $9.9 million, respectively. As of March 31, 2022, the aggregate notional amount of the Company's outstanding forward contracts used to hedge variability in cash flows on its Chinese Yuan denominated purchases were CNY68.3 million, all of which expired by December 31, 2022. Changes in fair value of any forward contracts that are determined to be ineffective are immediately reclassified from OCI into earnings. There were no amounts recognized due to ineffectiveness during the three-months ended March 31, 2023. The effects of fair value and cash flow hedge accounting on the Condensed Consolidated Statement of Earnings and Comprehensive Income for the periods ended March 31, were as follows:
|  | 2023 |  | 2022 |
(in thousands) |  | Interest expense, net | Other & foreign exchange loss, net |  | Cost of sales | Interest expense, net | Other & foreign exchange loss, net |
Total amounts of income and expense line items presented in the Condensed Consolidated Statement of Earnings in which the effects of fair value or cash flow hedges are recorded |  | $ | (570) |  | $ | (398) |  |  | 256,789 |  | (212) |  | (216) |  |
The effects of fair value and cash flow hedging |  |  |  |  |  |  |  |
| Gain or (loss) on cash flow hedging relationships |  |  |  |  |  |  |  |
|  | Interest contracts: |  |  |  |  |  |  |  |
|  |  | Amount of gain or (loss) reclassified from OCI to earnings |  | 3,196 |  | — |  |  | — |  | (29) |  | — |  |
|  | Cross currency swap contract |  |  |  |  |  |  |  |
|  |  | Amount of gain or (loss) reclassified from OCI to earnings |  | 1,339 |  | (1,816) |  |  | — |  | 21 |  | (2,967) |  |
|  | Forward contract |  |  |  |  |  |  |  |
|  |  | Amount of gain or (loss) reclassified from OCI to earnings |  | — |  | — |  |  | 163 | — |  | — |  |
The effects of derivative instruments on the Condensed Consolidated Statement of Earnings and Comprehensive Income for the three months ended March 31, 2023 and 2022 were as follows:
Cash Flow Hedging Relationships | Gain (Loss) Recognized in OCI |  | Location of Gain (Loss) Reclassified from OCI into Earnings | Gain (Loss) Reclassified from OCI into Earnings
(in thousands) | 2023 | 2022 |  |  | 2023 | 2022
Interest rate contracts | $ | (4,043) |  | $ | (1,805) |  |  | Interest expense | $ | 3,196 |  | $ | (29) |
Cross currency contracts | (2,279) |  | (7,548) |  |  | Interest expense | 1,339 |  | 21 |
Forward contracts | $ | (35) |  | $ | — |  |  | FX gain (loss) | (1,816) |  | (2,967) |
FX gain (loss) | $ | — |  | $ | — |  |  | Cost of goods sold | — |  | 163 |
Total | $ | (6,357) |  | $ | (9,353) |  |  |  | $ | 2,719 |  | $ | (2,812) |
For the three months ending March 31, 2023 losses on the net investment hedge and March 31, 2022 gains on net investment hedge of $0.2 million and $6.8 million were included in OCI, respectively. For the three months ending March 31, 2023, excluded gains of $1.2 million were reclassified from OCI to interest expense, while none were reported for the three months ended March 31, 2022. As of March 31, 2023, the aggregate fair values of the Company’s derivative instruments on the Condensed Consolidated Balance Sheet were comprised of an asset of $35.6 million, of which $18.0 million is included in other current assets, and the balance, or $17.7 million as other non-current assets, and a non-current liability of $11.5 million.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration